Intravenous Versus Perineural Dexmedetomidine as Adjuvant in Adductor Canal Block for Total Knee Arthroplasty

• Status: Recruiting
• Trial end date: 2022-07-31
• Target enrollment: 0
• Participant gender: All

Summary

Shivering increases the cardiac and systemic energy expenditure, oxygen consumption and carbon dioxide production. Definitive prevention and treatment of shivering is necessary to decrease the related complications and increase post-anesthetic comfort.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mansoura University
• Treatments: Dexmedetomidine; Levobupivacaine

Criteria

Inclusion Criteria:

• adult patients

• both genders

• American Society of Anesthesiologists physical status I and II

• scheduled for unilateral primary TKA under spinal anesthesia

Exclusion Criteria:

• chronic opioid use

• known allergy to the used drugs

• any contraindications to regional anesthesia like; patient refusal, coagulopathy, neuropathy or infection at the injection site